Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression
2020/04/07 by Eleanor Cole, Eleanor J. Cole, Katy H. Stimpson +31 · 46 citations
Medicine · Neuroscience · #Functional Brain Connectivity Studies #Neurological disorders and treatments #Transcranial Magnetic Stimulation Studies
paper · doi:10.1176/appi.ajp.2019.19070720
openalex publication_date 2020/04/07 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/31
Abstract
OBJECTIVE: New antidepressant treatments are needed that are effective, rapid acting, safe, and tolerable. Intermittent theta-burst stimulation (iTBS) is a noninvasive brain stimulation treatment that has been approved by the U.S. Food and Drug Administration for treatment-resistant depression. Recent methodological advances suggest that the current iTBS protocol might be improved through 1) treating patients with multiple sessions per day at optimally spaced intervals, 2) applying a higher overall pulse dose of stimulation, and 3) precision targeting of the left dorsolateral prefrontal cortex (DLPFC) to subgenual anterior cingulate cortex (sgACC) circuit. The authors examined the feasibility, tolerability, and preliminary efficacy of Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT), an accelerated, high-dose resting-state functional connectivity MRI (fcMRI)-guided iTBS protocol for treatment-resistant depression. METHODS: Twenty-two participants with treatment-resistant depression received open-label SAINT. fcMRI was used to individually target the region of the left DLPFC most anticorrelated with sgACC in each participant. Fifty iTBS sessions (1,800 pulses per session, 50-minute intersession interval) were delivered as 10 daily sessions over 5 consecutive days at 90% resting motor threshold (adjusted for cortical depth). Neuropsychological testing was conducted before and after SAINT. RESULTS: One participant withdrew, leaving a sample size of 21. Nineteen of 21 participants (90.5%) met remission criteria (defined as a score <11 on the Montgomery-Åsberg Depression Rating Scale). In the intent-to-treat analysis, 19 of 22 participants (86.4%) met remission criteria. Neuropsychological testing demonstrated no negative cognitive side effects. CONCLUSIONS: SAINT, an accelerated, high-dose, iTBS protocol with fcMRI-guided targeting, was well tolerated and safe. Double-blinded sham-controlled trials are needed to confirm the remission rate observed in this initial study.
Cited by
- Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial
- Functional Connectivity Mapping for rTMS Target Selection in Depression
- Excessive Censoring Degrades Individual-Specific Cortical Parcellations and Personalized TMS Targets
- Using Brain Imaging to Improve Spatial Targeting of Transcranial Magnetic Stimulation for Depression
- Personalized and Circuit-Based Transcranial Magnetic Stimulation: Evidence, Controversies, and Opportunities
- Identification of Personalized Transcranial Magnetic Stimulation Targets Based on Subgenual Cingulate Connectivity: An Independent Replication
- Resting fMRI-guided TMS results in subcortical and brain network modulation indexed by interleaved TMS/fMRI
- Translation of network mapping findings into therapeutic targets for transcranial magnetic stimulation
- Network-based near-scalp personalized brain stimulation targets
- Reward circuitry predicts the effects of fMRI-guided accelerated prolonged iTBS in treatment-resistant depression
- Considering brain state for individualized functional connectivity-based rTMS
- Personalizing transcranial electrical stimulation
- Neuroplastic effects of transcranial alternating current stimulation (tACS): from mechanisms to clinical trials
- Consensus review and considerations on TMS to treat depression: A comprehensive update endorsed by the National Network of Depression Centers, the Clinical TMS Society, and the International Federation of Clinical Neurophysiology
- A Scalable, Causal, and Energy Efficient Framework for Neural Decoding with Spiking Neural Networks
- Contrastive Diffusion Alignment: Learning Structured Latents for Controllable Generation
- Frontal Cortex Stimulation Modulates Attentional Circuits and Increases Anxiety-Potentiated Startle in Anxious Depression
- Convergent and divergent spatial topographies of individualized brain functional networks and their developmental origins
- The deep brain stimulation response network in Parkinson’s disease operates in the high beta band
- Basal forebrain activation improves working memory in senescent monkeys
- Why health authorities should endorse rTMS for treatment-resistant depression
- Opportunities of connectomic neuromodulation. [europepmc]
- Examining and Modulating Neural Circuits in Psychiatric Disorders With Transcranial Magnetic Stimulation and Electroencephalography: Present Practices and Future Developments. [europepmc]
- Theta burst stimulation for the acute treatment of major depressive disorder: A systematic review and meta-analysis. [europepmc]
- Brain stimulation and brain lesions converge on common causal circuits in neuropsychiatric disease. [europepmc]
- Intermittent theta burst stimulation of cerebellar vermis enhances fronto-cerebellar resting state functional connectivity in schizophrenia with predominant negative symptoms: A randomized controlled trial. [europepmc]
- Anatomical and fMRI-network comparison of multiple DLPFC targeting strategies for repetitive transcranial magnetic stimulation treatment of depression. [europepmc]
- Transcranial magnetic stimulation (TMS) for geriatric depression. [europepmc]
- Synaptic Plasticity 101: The Story of the AMPA Receptor for the Brain Stimulation Practitioner. [europepmc]
- Causal mapping of human brain function. [europepmc]
- Synaptic Mechanisms Regulating Mood State Transitions in Depression. [europepmc]
- The Problem and Potential of TMS' Infinite Parameter Space: A Targeted Review and Road Map Forward. [europepmc]
- Assessing the mechanisms of brain plasticity by transcranial magnetic stimulation. [europepmc]
- Astrocyte dysfunction drives abnormal resting-state functional connectivity in depression. [europepmc]
- New and emerging approaches to treat psychiatric disorders. [europepmc]
- Functional Connectivity Mapping for rTMS Target Selection in Depression. [europepmc]
- Accelerated TMS - moving quickly into the future of depression treatment. [europepmc]
- Closing the loop in psychiatric deep brain stimulation: physiology, psychometrics, and plasticity. [europepmc]
- The future of brain circuit-targeted therapeutics. [europepmc]
- Finding new and better treatments for psychiatric disorders. [europepmc]
- A systematic review and meta-analysis of resting-state fMRI in anxiety disorders: Need for data sharing to move the field forward. [europepmc]
- A systematic review and meta-analysis of neuromodulation therapies for substance use disorders. [europepmc]
- Accelerated Theta Burst Stimulation: Safety, Efficacy, and Future Advancements. [europepmc]
- Chronometric TMS-fMRI of personalized left dorsolateral prefrontal target reveals state-dependency of subgenual anterior cingulate cortex effects. [europepmc]
- Effectiveness of Personalized Hippocampal Network-Targeted Stimulation in Alzheimer Disease: A Randomized Clinical Trial. [europepmc]
- Neurobiological basis of stress resilience. [europepmc]
Related